A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.
Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...
KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...
A novel iPSC-derived lung-on-chip model mimics human alveolar tissue, revealing macrophage-driven tuberculosis responses.
NETs promote macrophage expression of T-cell chemokines and subsequently facilitate cytotoxic CD8+ T cell infiltration and granzyme B production, which drives kidney fibrosis in obstructive ...
BIRMINGHAM, Ala. – Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages — the white blood cells that defend the body by killing microbes, ...
Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...
The Korea Advanced Institute of Science and Technology (KAIST) researchers have developed a way to reprogram immune cells already inside tumours into cancer-killing machines. A drug injected directly ...
KAIST researchers unveil a new cancer therapy that reprograms immune cells inside tumours, eliminating lab-based CAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback